Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
A randomised study of lamivudine for prevention of HBV reactivation in HbsAg seropositive patients undergoing cytotoxic chemotherapy. Proceeding/Conference:Annual Meeting of the American Association for the Study of Liver Diseases, AASLD 2002 | 2002 | 109 |